Clinical Trial Detail

NCT ID NCT04003896
Title A Study to Evaluate Abemaciclib in Advanced Biliary Tract Carcinoma Who Failed Prior First Line Therapy
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Milton S. Hershey Medical Center
Indications

biliary tract cancer

cholangiocarcinoma

ampulla of Vater carcinoma

gallbladder carcinoma

Therapies

Abemaciclib

Age Groups: senior adult

No variant requirements are available.